Capital Advisor Network’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.4K Hold
46
– – 0.01% 119
2026
Q2
$13.8K Buy
+46
New +$13.9K 0.02% 116

Other funds holding ALNY

Capital Advisor Network's ALNY Position: Q3 2026 in Review

Capital Advisor Network held its Alnylam Pharmaceuticals (ALNY) position steady in Q3 2026 at 46 shares worth $11.4K. The position accounts for 0.01% of the portfolio, ranked #119.

Capital Advisor Network first reported a position in ALNY in Q2 2026 and has held it in 2 quarters since. The position peaked at $13.8K in Q2 2026. 730 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • Capital Advisor Network held 46 shares of Alnylam Pharmaceuticals worth $11.4K as of Q3 2026.
  • Capital Advisor Network left its Alnylam Pharmaceuticals share count unchanged in Q3 2026.
  • Alnylam Pharmaceuticals made up 0.01% of Capital Advisor Network's portfolio in Q3 2026, its #119 holding.
  • Capital Advisor Network first reported a position in Alnylam Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Capital Advisor Network's Alnylam Pharmaceuticals position peaked at $13.8K in Q2 2026.
  • 730 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Capital Advisor Network's 13F filing for Q3 2026, filed 13 Nov 2026.